chrisvoncsefalvay/vaers-outcomes huggingface dataset:
injection site pain and swelling - 8 hours post injection and continued through time of form submission (1/25)  Fever and chills - 12 hours post injection and continued through time of form submission (1/25) fever has been up to 100.6 and Tylenol has been taken to help.
tested positive for covid one week past her second Pfizer shot; tested positive for covid one week past her second Pfizer shot; This is a spontaneous report from a Non- contactable consumer. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. It was reported that someone in a local group posted that on an unspecified date, the patient (her nanny) has tested positive for COVID one week past her second Pfizer shot. The reporter stated that in the group, the poster mentioned that the patient has been asymptomatic and was tested as part of routing testing in the household and was tested twice and both tests were positive, so the poster did not think it's a false positive. The reporter was reporting this as a potential efficacy issue for the Pfizer Biontech Vaccine. On an unspecified date, the patient underwent lab tests and procedures which included covid-19 test which result showed tested positive for COVID. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Rapid palpations, Peripheral numbness, Nasal and lip numbness,  Throat " Fullness", noted posturing. Timeline of Events 1425 Vaccine Administered, Left Deltoid 1429 Symptoms Onset 1430 20mL Benadryl Administered; BP (132/84), HR 88, check lung sounds: WNL 1433 BP second check (BP 134/84) 1438 Pt noted lips, and toes felt tingly 1439 second HR check (HR 80) 1445 third BP check (132/82); pt claims past hx of stroke (x2) and SVT 1446 EMS was called 1449 Pt reports feeling of tightness in tongue and lips; pt reports similar symptoms to red wine and Novocain 1455 EMS arrived 1458 Pt was loaded into gurney and ambulance 1500 Pt depart in ambulance to the hospital
herpes voster also known as shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (herpes voster also known as shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (herpes voster also known as shingles) (seriousness criterion hospitalization). The patient was hospitalized for 5 days due to HERPES ZOSTER. At the time of the report, HERPES ZOSTER (herpes voster also known as shingles) was resolving.            No concomitant medications were reported.  No treatment information was provided.  Reported that after 2nd jab of Moderna -about 2 days after got a serious rash on back and upper leg- herpes voster also known as shingles. Just spent 5 days in hospital for treatment  Company Comment : This case concerns a patient with no reported relevant medical history, who experienced the unexpected serious event of herpes zoster. The date of onset was not reported, neither vaccination date. As per source document, the patient states the event occurred 2 days after the second dose of Moderna COVID-19 vaccine. The rechallenge was not applicable as no additional dose is expected. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient with no reported relevant medical history, who experienced the unexpected serious event of herpes zoster. The date of onset was not reported, neither vaccination date. As per source document, the patient states the event occurred 2 days after the second dose of Moderna COVID-19 vaccine. The rechallenge was not applicable as no additional dose is expected. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.
I did have the body aches, headache, tired symptoms the day right after the shot but the adverse reaction started a week later. I have very itchy red bumps in my scalp, on my back, stomach, neck, legs, arms and groin area. In some areas I may just have one or two and others more but they are very itchy like a bug bite. I have let my Doctor know but am just treating it with anti-itch cream, if it gets worse I will call my doctor for an appointment.
Pain and swelling at entire back of upper arm and back of shoulder on side of injection, gradually decreasing over three days.
itchy rash at the injection site; itchy rash at the injection site/itchy rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy rash at the injection site) and VACCINATION SITE RASH (itchy rash at the injection site/itchy rash at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Immunoglobulins increased. Concurrent medical conditions included Bug bite (bug bite allergy).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PRURITUS (itchy rash at the injection site) and VACCINATION SITE RASH (itchy rash at the injection site/itchy rash at the injection site). In March 2021, VACCINATION SITE PRURITUS (itchy rash at the injection site) and VACCINATION SITE RASH (itchy rash at the injection site/itchy rash at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications provided. No treatment medication was reported for the events happened for first dose.   This case was linked to MOD-2021-343352 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Oct-2021: Non Significant Follow Up received contains picture.
Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced TINNITUS (Tinnitus). The patient was treated with PREDNISONE at a dose of 1 dosage form and CYANOCOBALAMIN (B12 1000 SR) at a dose of 1 dosage form. On 20-Mar-2021, TINNITUS (Tinnitus) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by reporter. Treatment medications also included Fluid pill.
Besides pain at the injection site for about 4 days and chills on the third day after the shot, on the second day after my shot, my throat, tongue and lower part of my chin started to hurt fairly severely.   From my research, this did not seem like a typical side effect.    I had trouble sleeping, eating and swallowing without pain.  This is now 8 days after my shot and I still have pain.  I have taken motrin and this has helped, but only some.  As of today, my pain is not as bad as it had developed over the past week.  I reported this to my healthcare provider via a call first and all their only recommendation was to take motrin and not come in for a visit / investigation for 2 weeks which I did not agree with at all based on the severity.  These symptoms that I am reporting do not seem common and based on the severity I really question if i plan to take the second dose.  I really felt that this needed to be reported
Vaccines( COVID 19)  were picked up from our distributor clinic on 04/15/2022. Vaccines were received frozen. Once arrived at the clinic vaccines were placed in the freezer. We have been informed when those vaccines are placed in the freezer they are good for only 2 weeks even if the expiration date is 05/31/2022. Patient came in on 04/25/2022 and received a COVID 19 vaccine that day. From what we are being informed the vaccine is invalid due to improper storage.
Progress Notes at 6/28/2021  9:59 AM    Author: Service: ? Author Type: Nurse Practitioner   Filed: 6/28/2021 10:02 AM Encounter Date: 6/28/2021 Status: Signed   Editor: (Nurse Practitioner)     SUBJECTIVE: Chief Complaint Patient presents with ? Ringing in Ear     c/o left ear feeling clogged for on week      Patient is a 45 y.o. male with 1 week(s) history of feeling clogged in his left ear and ringing in his left ear. Temperature normal at home. Denies rash, ear drainage. Eating and drinking per normal routine: yes Treatments: Tried Q-tip, with worsening relief Does have a history of seasonal allergies, on Zyrtec daily.   Allergy: Patient has no known allergies.  Nurse Practitioner at 7/8/2021  1:33 PM SUBJECTIVE: Chief Complaint Patient presents with ? c/o left ear still plugged     Patient is a 45 y.o. male with continued left ear fullness and decreased hearing.  Office visit on June 28, 2021 noted to have fluid to bilateral ear, left worse than the right, there was mild erythema on his left TM.  He was advised to take Benadryl at night and Flonase, he felt relief the following day especially of his right ear, but left ear continues to feel full.  Denies rash, ear drainage. Eating and drinking per normal routine: yes   Allergy: Patient has no known allergies.   Review of Systems Constitutional: Negative for chills, diaphoresis, fever, malaise/fatigue and weight loss. HENT: Negative for congestion, ear discharge, ear pain, nosebleeds, sinus pain, sore throat and tinnitus.        + Ear fullness, decreased hearing  Respiratory: Negative for cough, hemoptysis, sputum production, shortness of breath, wheezing and stridor.   Cardiovascular: Negative for chest pain and palpitations. Musculoskeletal: Negative for myalgias. Skin: Negative for itching and rash. Neurological: Negative for dizziness and headaches.  All other systems reviewed and are negative.  Dr. at 9/14/2021  8:00 AM History of present illness: Patient is a 45-year-old male who reports sometime in January or February he began having a gradual decrease in his hearing on the left, constant high-pitched ringing sensation in the left ear as well as constant left ear pressure and fullness.  At the time he denied vertigo, facial weakness or numbness, headache, upper respiratory infection, nasal congestion, vision change or loss, head trauma.  He also reports of the last 3 years he has had an episode of a spinning vertigo lasting 2 to 3 hours at a time with no associated changes in hearing, ear pressure fullness or changes in ringing.  The last episode happened in the spring 2020.  He is recently been treated with antibiotics by PCP for presumed middle ear effusions.  He still continues to have a moderate hearing loss in left ear, constant ringing in left ear.  He was worked in for tympanograms which are normal type A  Bilaterally consistent with normal middle ear compliance..  He has no reported personal or family history of Ménière's disease.
Was advised that MOC called. Returned call to MOC. She stated she received a phone call from her son with the following complaints. Pain between his pectoral muscles, pain when swallowing with no trouble breathing, Feels as if something is stuck between his pectoral muscles. Described as if his lungs are up in his wind pipe. None of the symptoms presented until 10:00pm on 4/19/2022.. Advised to have him seen by PCP. However, PCP is out of office. Referred to Emergency Department.
Unable to breathe, elevated heart rate, throat was swelling, swollen arm on injection side.
Lower lip, chin, tongue went numb.  Went to the emergency room by ambulance.  Was given benadryl and sent home after a couple of hours
This spontaneous report was received from a medical assistant and refers to a 12 month old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 24-AUG-2017, the patient was vaccinated with improperly stored PROQUAD injection (lot # N010247 with expiration date on 25-SEP-2018, dose, anatomical location and route not reported) for prophylaxis, reconstituted with properly stored sterile diluent (manufacturer unknown). The administered vaccine experienced a temperature excursion of 6 degree Fahrenheit to 14 degree Fahrenheit for 18 hours. There was no previous temperature excursion and the call was not because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA000870: US-009507513-1710USA009270: US-009507513-1710USA009268: US-009507513-1710USA009267: US-009507513-1709USA001401:
Pt woke up next morning with headache (top of head), nausea, diarrhea, upper arm pain extending down below site of injection but above elbow. Limited range of motion, cannot lift arm, states it is muscular pain. Advised pt to contact physician. She has been icing, bracing (compression and taking ibuprofen). Pain limited range of motion has persisted since 8/18 - present.
"Throat felt tight, like it was closing".  Benadryl 25 mg by mouth repeated X 1 30 minutes later.
Nausea; chills; sweats; headache; fatigue for 24 hours
Client received Hep-A and Hep-B on 2/21/01. She became itchy, had swollen hands and extremities. She was nauseated and her headache became severe. Hives appeared on arms and trunk. At 21:00, she went to ER and was medicated and released. She was told not to complete the Hep-A and Hep-B in the future.
This spontaneous report as received from a registered nurse on 15-OCT-2014 concerning an unspecified number of patients. On an unknown date the patients was vaccinated with PNEUMOVAX 23 (route, dose was unknown) which was improperly stored. No adverse effects reported. No product quality complaint was involved. It was reported that this case was opened on 26-AUG-2014 for temperature inquiry only. The outcome of the events was unknown. This case is linked to cases MARRS # 1410USA008635, 1410USA013361, 1410USA013358, 1410USA013359 with same reporter link. Additional information is not expected.
Cellulitis at injection site. Pt developed cellulitis at illegible injection site of TD (Diphtheria + Tetanus Toxoid Adult). Treatment: Erythromycin 500 mg PO Q 8 hours for 7 days (allergic to penicillin, cephalosporins, and carbapenem). No further information available.
Within 15-minutes of vaccination, patient developed urticaria on their chest, which developed into a rash and hives. No throat/tongue swelling or shortness of breath noted by EMS. EMS transported patient to hospital and administered Benadryl (IV) in-route.
While I already had mold tinnitus and occasional vertigo that I resolved with self- positional otolith reset, after 2nd dose have had very loud tinnitus and changes in the sounds that make it hard to concentrate on computer programming work and hard to sleep. I have been adjusting white noise and using meditation to cope. Vertigo also is requiring more frequent otolith settling techniques. I hope the loudness of tinnitus ringing in my ears decreases. I am working to adjust my attitude and expectations, since I had to do this to deal with my initial tinnitus development after starting ACE inhibitor medication (a known ototoxic med lisinopril).
From telephone contact received on 06/11/2002, it was reported by a health care professional that a 2.5 year old female received 4th dose DTAP/HIB using Trihibit on 06/04/2002.  Two days later, patient had fever of 104 degree F. with swollen, and hot area at the injection site.  She went to ER and diagnosed with cellulitis.  Antibiotic Duraceft was prescribed for 10 days.
Immediately after administration the patient expressed that she did not feel quite right. Her eyes were bloodshot. She expressed that she experienced tingling in her lips and "pins and needles" in her face. Minutes after she jerked her back and expressed sharp pain down her back and in her stomach. We offered the patient water and waited around 20 minutes for her symptoms to subside. I followed up with a phone call two hours later and the patient said that she was still feeling miserable and had a headache and was laying down on the couch. I told her if anything changes to go to the emergency room and she is going to follow up with her PCP.
This spontaneous report was received from an 82 year old female patient concerning herself. The patient had a lumpectomy on an unspecified date 12 years ago and completed radiation therapy on an unspecified date 12 years ago, patient recently had a mastectomy in May 2012, with no treatment given after the mastectomy. Two years ago in 2011, the patient was vaccinated with ZOSTAVAX, (dose and lot not reported) subcutaneous. The patient states that at the time of the phone call she had shingles. The patient stated that the actual disease started 5 weeks ago on 14-FEB-2013. Initially the patient thought she had pulled a muscle in her rib cage as the developing zoster virus started with the pain. "Then a couple of days went by and a half dollar rash developed with multiple pustules." The rash was no longer evident however there was still a red discoloration were the rash was, without any raised rash. The patient stated that there was residual pain in the right front of her rib cage that leads around to the back on the same side. She was having great difficulty sleeping because of the pain. The patient reported that one day the pain would be gone and then the pain comes back. The patient went for a routine visit to her physician when she initially experienced the pain, for what she thought was a pulled muscle in her side, on 14-FEB-2013. On 15-FEB-2013, she went back to her physician because she had developed the shingles rash. The patient was prescribed acyclovir and hydrocodone as treatment for the shingles. The patient also stated she gets an upset stomach when she takes any narcotics, including the hydrocodone. The outcome of the even was unknown. The relatedness between the event and ZOSTAVAX was unknown. Additional information is not expected.
GRANDMOTHER MADE APPOINTMENT FOR GRANDSON BOOSTER; PRESENTED TO SITE WITH CDC CARD FOR BOOSTER; STAFF REVIEWED ALL QUESTIONS AND PROVIDED BOOSTER; WHILE PLACING LABEL OF BOOSTER ON CDC CARD NOTED BOOSTER HAD BEEN GIVEN 1/11/2022 THAT WAS LABELD ON BACK OF CARD THEREFORE THIS WAS A 4TH DOSE OF VACCINE
Presented with chest pain starting 1d after 2nd vaccine and worsening 3 d post vaccine. Found to have nstemi with troponin 11, normal echo, normal heart cath, negative urine drug screen.
Patient received Moderna COVID vaccine on 2/20/21 (lot # 012M20A), 3/18/21 (lot # 045A21A), 9/14/21(lot # 004F21A), and 4/20/22 (lot # 002M1A). On 6/14/22, patient admitted to our inpatient facility (med/surg. unit) with acute hypoxemic respiratory failure due to COVID-19 pneumonia, atrial fibrillation with rapid ventricular response, and ESRD on HD. Patient was discharged home on 6/16/22.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2022 at 11:04 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Mar-2022 at 11:04 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 05-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
Dizziness left arm and leg weakness Narrative:  employee has history of migraines and these are some of the same symptoms he has right eye twitch and left arm and leg weakness given thorazine, valproate, i L NS and 1MG Mg
None at time of vaccination... 10 days later my arm swelled at the site.... was extremely itchy, slight rash.. ( I thought I got stung by a bee)
I am a Menopausal woman and have not had periods for several months.  Following the vaccine I had very heavy bleeding for about 10 days each month for 4 months.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in an adult subject of unspecified gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On an unspecified date the subject received 3rd dose, 2nd dose and 1st dose of ENGERIX B (unknown). At an unspecified time after vaccination series completion with ENGERIX B, the subject experienced not responding to therapy and pharmaceutical product complaint. A total of six employees were vaccinated with three doses of ENGERIX B. All had titers drawn at an unknown period after the third dose and the titers were negative (0) for antibodies. There were two lots given to these six subjects at some point in the series, lots: AHBV13734AA and AHBV670AA. The lot numbers were reported as AHBV13734AA and AHBV670AA from the reporter; however, based on a safety lot number review, the lot numbers were updated to AHBVB734AA and AHBVB670AA respectively. For the other cases see A0891213A- A0891217A. Follow-up information was received on 09November 2010 via Quality Assurance, who stated there was no product complaint associate with the adverse event; therefore the pharmaceutical product complaint was voided.